Understanding inequities in precision oncology diagnostics.
Nat Cancer
; 4(6): 787-794, 2023 06.
Article
em En
| MEDLINE
| ID: mdl-37248397
ABSTRACT
Advances in molecular diagnostics have enabled the identification of targetable driver pathogenic variants, forming the basis of precision oncology care. However, the adoption of new technologies, such as next-generation sequencing (NGS) panels, can exacerbate healthcare disparities. Here, we summarize data on use patterns of advanced biomarker testing, highlight the disparities in both accessing NGS testing and using this data to match patients to appropriate personalized therapies and propose multidisciplinary strategies to address inequities looking forward.
Texto completo:
1
Coleções:
01-internacional
Contexto em Saúde:
1_ASSA2030
Base de dados:
MEDLINE
Assunto principal:
Neoplasias
Tipo de estudo:
Diagnostic_studies
/
Prognostic_studies
Aspecto:
Equity_inequality
Limite:
Humans
Idioma:
En
Revista:
Nat Cancer
Ano de publicação:
2023
Tipo de documento:
Article